AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. NHS
  4. [Form 4] Neuberger Berman High Yield Strategies Fund Inc. Insider Trading Activity

[Form 4] Neuberger Berman High Yield Strategies Fund Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Form 4 highlights: On 07/17/2025, portfolio manager Chris Kocinski purchased 6,000 common shares of Neuberger Berman High Yield Strategies Fund Inc. (NHS) at a volume-weighted average price of $7.3995 (price range $7.395-$7.41). This was an open-market 鈥淧鈥� code transaction and no shares were sold.

Following the trade, Kocinski鈥檚 direct beneficial ownership rose to 21,000 shares. No derivative securities were involved and there were no amendments to prior filings. The transaction suggests incremental insider confidence but represents a modest dollar amount (~$44k) relative to the fund鈥檚 market capitalization.

Punti salienti del Modulo 4: Il 17/07/2025, il gestore di portafoglio Chris Kocinski ha acquistato 6.000 azioni ordinarie di Neuberger Berman High Yield Strategies Fund Inc. (NHS) a un prezzo medio ponderato per volume di $7,3995 (range di prezzo $7,395-$7,41). Si 猫 trattato di una transazione di tipo 鈥淧鈥� a mercato aperto e non sono state vendute azioni.

Dopo l鈥檕perazione, la propriet脿 diretta di Kocinski 猫 salita a 21.000 azioni. Non sono stati coinvolti strumenti derivati n茅 sono state apportate modifiche a precedenti comunicazioni. La transazione indica una fiducia incrementale da parte dell鈥檌nsider, ma rappresenta un valore modesto (~44.000$) rispetto alla capitalizzazione di mercato del fondo.

Aspectos destacados del Formulario 4: El 17/07/2025, el gestor de cartera Chris Kocinski compr贸 6.000 acciones comunes de Neuberger Berman High Yield Strategies Fund Inc. (NHS) a un precio promedio ponderado por volumen de $7.3995 (rango de precio $7.395-$7.41). Esta fue una transacci贸n de c贸digo 鈥淧鈥� de mercado abierto y no se vendieron acciones.

Tras la operaci贸n, la propiedad directa de Kocinski aument贸 a 21.000 acciones. No se involucraron valores derivados ni hubo enmiendas a presentaciones anteriores. La transacci贸n sugiere una confianza incremental del insider, pero representa un monto modesto (~44.000$) en relaci贸n con la capitalizaci贸n de mercado del fondo.

Form 4 欤检殧 雮挫毄: 2025雲� 7鞗� 17鞚�, 韽姼韽措Μ鞓� 毵る媹鞝� 韥Μ鞀� 旖旍箿鞀ろ偆臧� Neuberger Berman High Yield Strategies Fund Inc. (NHS)鞚� 氤错喌欤� 6,000欤茧ゼ 瓯半灅霟� 臧�欷� 韽夑窢 臧�瓴� $7.3995 (臧�瓴� 氩旍渼 $7.395-$7.41)鞐� 毵れ垬頄堨姷雼堧嫟. 鞚措姅 瓿店皽鞁滌灔 鈥淧鈥� 旖旊摐 瓯半灅鞓�鞙茧┌ 欤检嫕鞚� 毵る弰霅橃 鞎婌晿鞀惦媹雼�.

瓯半灅 頉� 旖旍箿鞀ろ偆鞚� 歆侅爲 氤挫湢 歆�攵勳潃 21,000欤�搿� 歃濌皜頄堨姷雼堧嫟. 韺岇儩靸來拡鞚� 韽暔霅橃 鞎婌晿瓿� 鞚挫爠 鞁犼碃靹� 靾橃爼霃� 鞐嗢棃鞀惦媹雼�. 鞚� 瓯半灅電� 雮措秬鞛愳潣 鞁犽 歃濌皜毳� 鞁滌偓頃橃毵�, 韼�霌� 鞁滉皜齑濎暋 雽�牍� 鞎� 44,000雼煬搿� 旮堨暋鞚� 韥 鞎婌姷雼堧嫟.

Points cl茅s du Formulaire 4 : Le 17/07/2025, le gestionnaire de portefeuille Chris Kocinski a achet茅 6 000 actions ordinaires de Neuberger Berman High Yield Strategies Fund Inc. (NHS) 脿 un prix moyen pond茅r茅 par volume de 7,3995 $ (fourchette de prix 7,395 $-7,41 $). Il s鈥檃gissait d鈥檜ne transaction 芦 P 禄 en march茅 ouvert et aucune action n鈥檃 茅t茅 vendue.

Apr猫s la transaction, la propri茅t茅 directe de Kocinski est mont茅e 脿 21 000 actions. Aucun titre d茅riv茅 n鈥檃 茅t茅 impliqu茅 et aucune modification n鈥檃 茅t茅 apport茅e aux d茅clarations pr茅c茅dentes. La transaction sugg猫re une confiance accrue de l鈥檌niti茅 mais repr茅sente un montant modeste (~44 000 $) par rapport 脿 la capitalisation boursi猫re du fonds.

Formular 4 Highlights: Am 17.07.2025 kaufte Portfoliomanager Chris Kocinski 6.000 Stammaktien von Neuberger Berman High Yield Strategies Fund Inc. (NHS) zu einem volumengewichteten Durchschnittspreis von 7,3995 $ (Preisspanne 7,395 $鈥�7,41 $). Dies war eine 翱蹿蹿别苍尘补谤办迟-鈥淧鈥�-颁辞诲别-Transaktion, und es wurden keine Aktien verkauft.

Nach dem Handel stieg Kocinskis direkte wirtschaftliche Eigent眉merschaft auf 21.000 Aktien. Es waren keine Derivate beteiligt und es gab keine 脛nderungen an fr眉heren Meldungen. Die Transaktion deutet auf ein gesteigertes Insider-Vertrauen hin, stellt jedoch einen moderaten Geldbetrag (~44.000 $) im Verh盲ltnis zur Marktkapitalisierung des Fonds dar.

Positive
  • Insider purchase: 6,000 shares acquired at $7.3995, raising ownership to 21,000 shares鈥攐ften read as a confidence signal.
Negative
  • None.

Insights

TL;DR: Modest insider buy; positive signal but limited capital deployed.

The Form 4 shows a small open-market purchase, increasing Kocinski鈥檚 stake by 40%. Insider buying鈥攅specially from a portfolio manager鈥攖ends to be interpreted as a vote of confidence in future NAV performance or discount narrowing. However, the absolute size is immaterial to fund liquidity and unlikely to move NHS鈥檚 share price on its own. I classify the filing as low-impact positive; it supports sentiment but offers no fundamental change to earnings, leverage, or distribution policy.

Punti salienti del Modulo 4: Il 17/07/2025, il gestore di portafoglio Chris Kocinski ha acquistato 6.000 azioni ordinarie di Neuberger Berman High Yield Strategies Fund Inc. (NHS) a un prezzo medio ponderato per volume di $7,3995 (range di prezzo $7,395-$7,41). Si 猫 trattato di una transazione di tipo 鈥淧鈥� a mercato aperto e non sono state vendute azioni.

Dopo l鈥檕perazione, la propriet脿 diretta di Kocinski 猫 salita a 21.000 azioni. Non sono stati coinvolti strumenti derivati n茅 sono state apportate modifiche a precedenti comunicazioni. La transazione indica una fiducia incrementale da parte dell鈥檌nsider, ma rappresenta un valore modesto (~44.000$) rispetto alla capitalizzazione di mercato del fondo.

Aspectos destacados del Formulario 4: El 17/07/2025, el gestor de cartera Chris Kocinski compr贸 6.000 acciones comunes de Neuberger Berman High Yield Strategies Fund Inc. (NHS) a un precio promedio ponderado por volumen de $7.3995 (rango de precio $7.395-$7.41). Esta fue una transacci贸n de c贸digo 鈥淧鈥� de mercado abierto y no se vendieron acciones.

Tras la operaci贸n, la propiedad directa de Kocinski aument贸 a 21.000 acciones. No se involucraron valores derivados ni hubo enmiendas a presentaciones anteriores. La transacci贸n sugiere una confianza incremental del insider, pero representa un monto modesto (~44.000$) en relaci贸n con la capitalizaci贸n de mercado del fondo.

Form 4 欤检殧 雮挫毄: 2025雲� 7鞗� 17鞚�, 韽姼韽措Μ鞓� 毵る媹鞝� 韥Μ鞀� 旖旍箿鞀ろ偆臧� Neuberger Berman High Yield Strategies Fund Inc. (NHS)鞚� 氤错喌欤� 6,000欤茧ゼ 瓯半灅霟� 臧�欷� 韽夑窢 臧�瓴� $7.3995 (臧�瓴� 氩旍渼 $7.395-$7.41)鞐� 毵れ垬頄堨姷雼堧嫟. 鞚措姅 瓿店皽鞁滌灔 鈥淧鈥� 旖旊摐 瓯半灅鞓�鞙茧┌ 欤检嫕鞚� 毵る弰霅橃 鞎婌晿鞀惦媹雼�.

瓯半灅 頉� 旖旍箿鞀ろ偆鞚� 歆侅爲 氤挫湢 歆�攵勳潃 21,000欤�搿� 歃濌皜頄堨姷雼堧嫟. 韺岇儩靸來拡鞚� 韽暔霅橃 鞎婌晿瓿� 鞚挫爠 鞁犼碃靹� 靾橃爼霃� 鞐嗢棃鞀惦媹雼�. 鞚� 瓯半灅電� 雮措秬鞛愳潣 鞁犽 歃濌皜毳� 鞁滌偓頃橃毵�, 韼�霌� 鞁滉皜齑濎暋 雽�牍� 鞎� 44,000雼煬搿� 旮堨暋鞚� 韥 鞎婌姷雼堧嫟.

Points cl茅s du Formulaire 4 : Le 17/07/2025, le gestionnaire de portefeuille Chris Kocinski a achet茅 6 000 actions ordinaires de Neuberger Berman High Yield Strategies Fund Inc. (NHS) 脿 un prix moyen pond茅r茅 par volume de 7,3995 $ (fourchette de prix 7,395 $-7,41 $). Il s鈥檃gissait d鈥檜ne transaction 芦 P 禄 en march茅 ouvert et aucune action n鈥檃 茅t茅 vendue.

Apr猫s la transaction, la propri茅t茅 directe de Kocinski est mont茅e 脿 21 000 actions. Aucun titre d茅riv茅 n鈥檃 茅t茅 impliqu茅 et aucune modification n鈥檃 茅t茅 apport茅e aux d茅clarations pr茅c茅dentes. La transaction sugg猫re une confiance accrue de l鈥檌niti茅 mais repr茅sente un montant modeste (~44 000 $) par rapport 脿 la capitalisation boursi猫re du fonds.

Formular 4 Highlights: Am 17.07.2025 kaufte Portfoliomanager Chris Kocinski 6.000 Stammaktien von Neuberger Berman High Yield Strategies Fund Inc. (NHS) zu einem volumengewichteten Durchschnittspreis von 7,3995 $ (Preisspanne 7,395 $鈥�7,41 $). Dies war eine 翱蹿蹿别苍尘补谤办迟-鈥淧鈥�-颁辞诲别-Transaktion, und es wurden keine Aktien verkauft.

Nach dem Handel stieg Kocinskis direkte wirtschaftliche Eigent眉merschaft auf 21.000 Aktien. Es waren keine Derivate beteiligt und es gab keine 脛nderungen an fr眉heren Meldungen. Die Transaktion deutet auf ein gesteigertes Insider-Vertrauen hin, stellt jedoch einen moderaten Geldbetrag (~44.000 $) im Verh盲ltnis zur Marktkapitalisierung des Fonds dar.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Kocinski Chris
(Last) (First) (Middle)
190 SOUTH LASALLE STREET
NEUBERGER BERMAN INVESTMENT ADVISERS
(Street)
CHICAGO IL 60603
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Neuberger Berman High Yield Strategies Fund Inc. [ NHS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
Portfolio Manager
3. Date of Earliest Transaction (Month/Day/Year)
07/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/17/2025 P 6,000 A $7.3995(1) 21,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares were purchased in separate transactions. The range of prices for the transactions reported on this line was $7.395 to $7.41. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
/s/ Jennifer R. Gonzalez, as attorney-in-fact for Chris Kocinski 07/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many NHS shares did Chris Kocinski buy?

6,000 common shares were purchased on 07/17/2025.

What was the average price paid for NHS shares?

The volume-weighted average price was $7.3995, with a $7.395鈥�$7.41 range.

What is Kocinski鈥檚 total ownership after the trade?

He now directly holds 21,000 NHS shares.

Was any stock sold in this Form 4?

No. The filing shows only an acquisition (code P); no dispositions were reported.

Does the filing report any derivative securities?

No derivative positions were disclosed in Table II.
Stock NHS logo
Neuberger Berman High Yield Strategies

NYSE:NHS

NHS Rankings

#4074 Ranked by Market Cap
#47 Ranked by Dividends

NHS Latest News

Aug 29, 2025
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
Jul 31, 2025
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
Jun 30, 2025
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
May 30, 2025
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
Apr 30, 2025
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION

NHS Latest SEC Filings

Jun 24, 2025
[NPORT-P] Neuberger Berman High Yield Strategies Fund Inc. SEC Filing

NHS Stock Data

229.81M
30.39M
35.1%
0.12%
Asset Management
Financial Services
United States
New York